Our new product video is here! 📽️ Explore the workflow of our cutting-edge diagnostics and read how PsorX is already revolutionizing the labs of leading diagnostic pioneers.
For patients of all ages, accurate diagnosis of chronic inflammatory skin diseases is crucial. Psoriasis or eczema? Traditional methods leave room for uncertainty, but Dermagnostix delivers an objective, molecular-based solution to support personalized treatment decisions. Every patient deserves the best care, and we're committed to providing dermatopathologists with innovative, reliable, and rapid diagnostics that fulfill this mission.
🎥 See Molecular Diagnostics in Action
Watch our new product video to discover how PsorX-LabDisk is transforming dermatopathology.
🌍 The Voice of Diagnostic Pioneers
Discover how the Dermagnostix system is already revolutionizing leading dermatopathology laboratories.
"Pathology is changing - by using modern methods such as molecular diagnostics in combination with a trained view through the microscope, we achieve greater precision and objectivity and set new quality standards. The innovative Dermagnostix products are therefore a perfect addition to our service portfolio. The excellent customer service should also be highlighted: if you have any questions or challenges, they will always find a quick solution. As a pioneers in pathological molecular diagnostics, we greatly appreciate the cooperation with Dermagnostix."
Prof. Dr. Dr. Jörg Kriegsmann
MVZ für Histologie, Zytologie & Molekulare Diagnostik Trier
🔎 Your Diagnosis Skills Put to the Test Thank you for participating in our HistoQuiz.
The results of our HistoQuiz on Instagram and LinkedIn(60% psoriasis, 40% eczema)reflect the clinical and laboratory reality, as the misdiagnosis rate of patients with psoriasis and eczema is up to 50%. With PsorX-LabDisk, your lab can eliminate guesswork and rely on precise, molecular insights to distinguish between psoriasis and eczema. It’s the objective and reliable solution for delivering accurate diagnoses and improving patient outcomes.
By the way, the correct answer was 👉 psoriasis. Thank you for participating and helping us highlight the importance of objective diagnostics.
🙌 Together, we’re raising awareness and driving precision in dermatology.
Your Dermagnostix Team
If you like our newsletter, you are welcome to share it within your network. Subscribe here.
Dermagnostix GmbH, Engesserstraße 4a, 79108 Freiburg, Baden-Württemberg, Germany